Bostal LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 18 Mayfield Avenue, Edison, New Jersey (NJ) 08837, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3008953516 Β· DUNS 362785011
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2024-12-04
- VAIDrug Quality Assurance2023-04-05
- VAIDrug Quality Assurance2018-01-05
- VAIDrug Quality Assurance2016-05-25
- VAIDrug Quality Assurance2013-12-18
- VAIDrug Quality Assurance2012-06-05
- NAIDrug Quality Assurance2011-06-03
Drugs this plant is listed as making
3 distinct drugs across 9 products name this site in their FDA label.
- delafloxacin meglumineMelinta Therapeutics, LLC
- FenofibrateWestminster Pharmaceuticals, LLC
- TadalafilBostal LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.